Current and Emerging Therapeutic Strategies for the Treatment of Meibomian Gland Dysfunction (MGD)

Meibomian gland (MG) dysfunction (MGD) is a multifactorial, chronic condition of the eyelids, leading to eye irritation, inflammation and ocular surface disease. Initial conservative therapy often includes a combination of warm compresses in addition to baby shampoo or eyelid wipes. The practice of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Drugs (New York, N.Y.) N.Y.), 2015-07, Vol.75 (11), p.1177-1185
Hauptverfasser: Thode, Adam R., Latkany, Robert A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1185
container_issue 11
container_start_page 1177
container_title Drugs (New York, N.Y.)
container_volume 75
creator Thode, Adam R.
Latkany, Robert A.
description Meibomian gland (MG) dysfunction (MGD) is a multifactorial, chronic condition of the eyelids, leading to eye irritation, inflammation and ocular surface disease. Initial conservative therapy often includes a combination of warm compresses in addition to baby shampoo or eyelid wipes. The practice of lid hygiene dates back to the 1950s, when selenium sulfide-based shampoo was first used to treat seborrhoeic dermatitis of the eyelids. Today, tear-free baby shampoo has replaced dandruff shampoo for MGD treatment and offers symptom relief in selected patients. However, many will not achieve significant improvement on this therapy alone; some may even develop an allergy to the added dyes and fragrances in these products. Other manual and mechanical techniques to treat MGD include MG expression and massage, MG probing and LipiFlow ® . While potentially effective in patients with moderate MGD, these procedures are more invasive and may be cost prohibitive. Pharmacological treatments are another course of action. Supplements rich in omega-3 fatty acids have been shown to improve both MGD and dry eye symptoms. Tea tree oil, specifically the terpenin-4-ol component, is especially effective in treating MGD associated with Demodex mites. Topical antibiotics, such as azithromycin, or systemic antibiotics, such as doxycycline or azithromycin, can improve MGD symptoms both by altering the ocular flora and through anti-inflammatory mechanisms. Addressing and treating concurrent ocular allergy is integral to symptom management. Topical N -acetylcysteine and topical cyclosporine can both be effective therapeutic adjuncts in patients with concurrent dry eye. A short course of topical steroid may be used in some severe cases, with monitoring for steroid-induced glaucoma and cataracts. While the standard method to treat MGD is simply warm compresses and baby shampoo, a more tailored approach to address the multiple aetiologies of the disease is suggested.
doi_str_mv 10.1007/s40265-015-0432-8
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1697220795</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1697220795</sourcerecordid><originalsourceid>FETCH-LOGICAL-c508t-ef4b463a42bf7430b8fcc574d67d7f2c8774ac971ba131f66b15740f333ce1873</originalsourceid><addsrcrecordid>eNp1kTFv2zAQhYkgRew6_QFdCgJZ0kEJj5RIaSycxA0Qo0PcmaDooy3DklySGvLvQ8VOERToQBDEfe_dHR8hX4HdAGPqNuSMyyJjkE4ueFaekSmAqjKoCnZOpowBz6SUakI-h7Abn1VRXZAJlyAYlGpK6vngPXaRmm5N71v0m6bb0NUWvTngEBtLn6M3ETcNBup6T-MW6cqjie2o6h1dYlP3bWM6utiPJncvwQ2djU3f0evl4u77JfnkzD7gl9M9I78f7lfzn9nTr8Xj_MdTZgtWxgxdXudSmJzXTuWC1aWztlD5Wqq1ctyWSuXGVgpqAwKclDWkKnNCCItpFzEj10ffg-__DBiibptgcZ-mwn4IGmSlOGeqKhJ69Q-66wffpek0KJC8AvVmCEfK-j4Ej04ffNMa_6KB6TEAfQxApwD0GIAuk-bbyXmoW1z_Vbz_eAL4EQip1G3Qf2j9X9dXATSPIA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1716291787</pqid></control><display><type>article</type><title>Current and Emerging Therapeutic Strategies for the Treatment of Meibomian Gland Dysfunction (MGD)</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Thode, Adam R. ; Latkany, Robert A.</creator><creatorcontrib>Thode, Adam R. ; Latkany, Robert A.</creatorcontrib><description>Meibomian gland (MG) dysfunction (MGD) is a multifactorial, chronic condition of the eyelids, leading to eye irritation, inflammation and ocular surface disease. Initial conservative therapy often includes a combination of warm compresses in addition to baby shampoo or eyelid wipes. The practice of lid hygiene dates back to the 1950s, when selenium sulfide-based shampoo was first used to treat seborrhoeic dermatitis of the eyelids. Today, tear-free baby shampoo has replaced dandruff shampoo for MGD treatment and offers symptom relief in selected patients. However, many will not achieve significant improvement on this therapy alone; some may even develop an allergy to the added dyes and fragrances in these products. Other manual and mechanical techniques to treat MGD include MG expression and massage, MG probing and LipiFlow ® . While potentially effective in patients with moderate MGD, these procedures are more invasive and may be cost prohibitive. Pharmacological treatments are another course of action. Supplements rich in omega-3 fatty acids have been shown to improve both MGD and dry eye symptoms. Tea tree oil, specifically the terpenin-4-ol component, is especially effective in treating MGD associated with Demodex mites. Topical antibiotics, such as azithromycin, or systemic antibiotics, such as doxycycline or azithromycin, can improve MGD symptoms both by altering the ocular flora and through anti-inflammatory mechanisms. Addressing and treating concurrent ocular allergy is integral to symptom management. Topical N -acetylcysteine and topical cyclosporine can both be effective therapeutic adjuncts in patients with concurrent dry eye. A short course of topical steroid may be used in some severe cases, with monitoring for steroid-induced glaucoma and cataracts. While the standard method to treat MGD is simply warm compresses and baby shampoo, a more tailored approach to address the multiple aetiologies of the disease is suggested.</description><identifier>ISSN: 0012-6667</identifier><identifier>EISSN: 1179-1950</identifier><identifier>DOI: 10.1007/s40265-015-0432-8</identifier><identifier>PMID: 26130187</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Anti-Inflammatory Agents - administration &amp; dosage ; Anti-Inflammatory Agents - therapeutic use ; Antibiotics ; Dermatitis ; Drug Design ; Dyes ; Eyelid Diseases - drug therapy ; Eyelid Diseases - physiopathology ; Hair Preparations - chemistry ; Humans ; Hygiene ; Inflammation ; Inflammation - drug therapy ; Inflammation - physiopathology ; Internal Medicine ; Leading Article ; Medicine ; Medicine &amp; Public Health ; Meibomian Glands - physiopathology ; Patients ; Pharmacology/Toxicology ; Pharmacotherapy ; Rosacea ; Selenium ; Steroids ; Surfactants</subject><ispartof>Drugs (New York, N.Y.), 2015-07, Vol.75 (11), p.1177-1185</ispartof><rights>Springer International Publishing Switzerland 2015</rights><rights>Copyright Springer Science &amp; Business Media Jul 2015</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c508t-ef4b463a42bf7430b8fcc574d67d7f2c8774ac971ba131f66b15740f333ce1873</citedby><cites>FETCH-LOGICAL-c508t-ef4b463a42bf7430b8fcc574d67d7f2c8774ac971ba131f66b15740f333ce1873</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s40265-015-0432-8$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s40265-015-0432-8$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26130187$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Thode, Adam R.</creatorcontrib><creatorcontrib>Latkany, Robert A.</creatorcontrib><title>Current and Emerging Therapeutic Strategies for the Treatment of Meibomian Gland Dysfunction (MGD)</title><title>Drugs (New York, N.Y.)</title><addtitle>Drugs</addtitle><addtitle>Drugs</addtitle><description>Meibomian gland (MG) dysfunction (MGD) is a multifactorial, chronic condition of the eyelids, leading to eye irritation, inflammation and ocular surface disease. Initial conservative therapy often includes a combination of warm compresses in addition to baby shampoo or eyelid wipes. The practice of lid hygiene dates back to the 1950s, when selenium sulfide-based shampoo was first used to treat seborrhoeic dermatitis of the eyelids. Today, tear-free baby shampoo has replaced dandruff shampoo for MGD treatment and offers symptom relief in selected patients. However, many will not achieve significant improvement on this therapy alone; some may even develop an allergy to the added dyes and fragrances in these products. Other manual and mechanical techniques to treat MGD include MG expression and massage, MG probing and LipiFlow ® . While potentially effective in patients with moderate MGD, these procedures are more invasive and may be cost prohibitive. Pharmacological treatments are another course of action. Supplements rich in omega-3 fatty acids have been shown to improve both MGD and dry eye symptoms. Tea tree oil, specifically the terpenin-4-ol component, is especially effective in treating MGD associated with Demodex mites. Topical antibiotics, such as azithromycin, or systemic antibiotics, such as doxycycline or azithromycin, can improve MGD symptoms both by altering the ocular flora and through anti-inflammatory mechanisms. Addressing and treating concurrent ocular allergy is integral to symptom management. Topical N -acetylcysteine and topical cyclosporine can both be effective therapeutic adjuncts in patients with concurrent dry eye. A short course of topical steroid may be used in some severe cases, with monitoring for steroid-induced glaucoma and cataracts. While the standard method to treat MGD is simply warm compresses and baby shampoo, a more tailored approach to address the multiple aetiologies of the disease is suggested.</description><subject>Anti-Inflammatory Agents - administration &amp; dosage</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Antibiotics</subject><subject>Dermatitis</subject><subject>Drug Design</subject><subject>Dyes</subject><subject>Eyelid Diseases - drug therapy</subject><subject>Eyelid Diseases - physiopathology</subject><subject>Hair Preparations - chemistry</subject><subject>Humans</subject><subject>Hygiene</subject><subject>Inflammation</subject><subject>Inflammation - drug therapy</subject><subject>Inflammation - physiopathology</subject><subject>Internal Medicine</subject><subject>Leading Article</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Meibomian Glands - physiopathology</subject><subject>Patients</subject><subject>Pharmacology/Toxicology</subject><subject>Pharmacotherapy</subject><subject>Rosacea</subject><subject>Selenium</subject><subject>Steroids</subject><subject>Surfactants</subject><issn>0012-6667</issn><issn>1179-1950</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kTFv2zAQhYkgRew6_QFdCgJZ0kEJj5RIaSycxA0Qo0PcmaDooy3DklySGvLvQ8VOERToQBDEfe_dHR8hX4HdAGPqNuSMyyJjkE4ueFaekSmAqjKoCnZOpowBz6SUakI-h7Abn1VRXZAJlyAYlGpK6vngPXaRmm5N71v0m6bb0NUWvTngEBtLn6M3ETcNBup6T-MW6cqjie2o6h1dYlP3bWM6utiPJncvwQ2djU3f0evl4u77JfnkzD7gl9M9I78f7lfzn9nTr8Xj_MdTZgtWxgxdXudSmJzXTuWC1aWztlD5Wqq1ctyWSuXGVgpqAwKclDWkKnNCCItpFzEj10ffg-__DBiibptgcZ-mwn4IGmSlOGeqKhJ69Q-66wffpek0KJC8AvVmCEfK-j4Ej04ffNMa_6KB6TEAfQxApwD0GIAuk-bbyXmoW1z_Vbz_eAL4EQip1G3Qf2j9X9dXATSPIA</recordid><startdate>20150701</startdate><enddate>20150701</enddate><creator>Thode, Adam R.</creator><creator>Latkany, Robert A.</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>7QO</scope><scope>7RV</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20150701</creationdate><title>Current and Emerging Therapeutic Strategies for the Treatment of Meibomian Gland Dysfunction (MGD)</title><author>Thode, Adam R. ; Latkany, Robert A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c508t-ef4b463a42bf7430b8fcc574d67d7f2c8774ac971ba131f66b15740f333ce1873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Anti-Inflammatory Agents - administration &amp; dosage</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Antibiotics</topic><topic>Dermatitis</topic><topic>Drug Design</topic><topic>Dyes</topic><topic>Eyelid Diseases - drug therapy</topic><topic>Eyelid Diseases - physiopathology</topic><topic>Hair Preparations - chemistry</topic><topic>Humans</topic><topic>Hygiene</topic><topic>Inflammation</topic><topic>Inflammation - drug therapy</topic><topic>Inflammation - physiopathology</topic><topic>Internal Medicine</topic><topic>Leading Article</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Meibomian Glands - physiopathology</topic><topic>Patients</topic><topic>Pharmacology/Toxicology</topic><topic>Pharmacotherapy</topic><topic>Rosacea</topic><topic>Selenium</topic><topic>Steroids</topic><topic>Surfactants</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thode, Adam R.</creatorcontrib><creatorcontrib>Latkany, Robert A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Drugs (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thode, Adam R.</au><au>Latkany, Robert A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Current and Emerging Therapeutic Strategies for the Treatment of Meibomian Gland Dysfunction (MGD)</atitle><jtitle>Drugs (New York, N.Y.)</jtitle><stitle>Drugs</stitle><addtitle>Drugs</addtitle><date>2015-07-01</date><risdate>2015</risdate><volume>75</volume><issue>11</issue><spage>1177</spage><epage>1185</epage><pages>1177-1185</pages><issn>0012-6667</issn><eissn>1179-1950</eissn><abstract>Meibomian gland (MG) dysfunction (MGD) is a multifactorial, chronic condition of the eyelids, leading to eye irritation, inflammation and ocular surface disease. Initial conservative therapy often includes a combination of warm compresses in addition to baby shampoo or eyelid wipes. The practice of lid hygiene dates back to the 1950s, when selenium sulfide-based shampoo was first used to treat seborrhoeic dermatitis of the eyelids. Today, tear-free baby shampoo has replaced dandruff shampoo for MGD treatment and offers symptom relief in selected patients. However, many will not achieve significant improvement on this therapy alone; some may even develop an allergy to the added dyes and fragrances in these products. Other manual and mechanical techniques to treat MGD include MG expression and massage, MG probing and LipiFlow ® . While potentially effective in patients with moderate MGD, these procedures are more invasive and may be cost prohibitive. Pharmacological treatments are another course of action. Supplements rich in omega-3 fatty acids have been shown to improve both MGD and dry eye symptoms. Tea tree oil, specifically the terpenin-4-ol component, is especially effective in treating MGD associated with Demodex mites. Topical antibiotics, such as azithromycin, or systemic antibiotics, such as doxycycline or azithromycin, can improve MGD symptoms both by altering the ocular flora and through anti-inflammatory mechanisms. Addressing and treating concurrent ocular allergy is integral to symptom management. Topical N -acetylcysteine and topical cyclosporine can both be effective therapeutic adjuncts in patients with concurrent dry eye. A short course of topical steroid may be used in some severe cases, with monitoring for steroid-induced glaucoma and cataracts. While the standard method to treat MGD is simply warm compresses and baby shampoo, a more tailored approach to address the multiple aetiologies of the disease is suggested.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>26130187</pmid><doi>10.1007/s40265-015-0432-8</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0012-6667
ispartof Drugs (New York, N.Y.), 2015-07, Vol.75 (11), p.1177-1185
issn 0012-6667
1179-1950
language eng
recordid cdi_proquest_miscellaneous_1697220795
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Anti-Inflammatory Agents - administration & dosage
Anti-Inflammatory Agents - therapeutic use
Antibiotics
Dermatitis
Drug Design
Dyes
Eyelid Diseases - drug therapy
Eyelid Diseases - physiopathology
Hair Preparations - chemistry
Humans
Hygiene
Inflammation
Inflammation - drug therapy
Inflammation - physiopathology
Internal Medicine
Leading Article
Medicine
Medicine & Public Health
Meibomian Glands - physiopathology
Patients
Pharmacology/Toxicology
Pharmacotherapy
Rosacea
Selenium
Steroids
Surfactants
title Current and Emerging Therapeutic Strategies for the Treatment of Meibomian Gland Dysfunction (MGD)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T06%3A34%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Current%20and%20Emerging%20Therapeutic%20Strategies%20for%20the%20Treatment%20of%20Meibomian%20Gland%20Dysfunction%20(MGD)&rft.jtitle=Drugs%20(New%20York,%20N.Y.)&rft.au=Thode,%20Adam%20R.&rft.date=2015-07-01&rft.volume=75&rft.issue=11&rft.spage=1177&rft.epage=1185&rft.pages=1177-1185&rft.issn=0012-6667&rft.eissn=1179-1950&rft_id=info:doi/10.1007/s40265-015-0432-8&rft_dat=%3Cproquest_cross%3E1697220795%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1716291787&rft_id=info:pmid/26130187&rfr_iscdi=true